Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Do Hedge Funds Think of MedAssets, Inc. (MDAS)?

As we already know from media reports and hedge fund investor letters, many hedge funds lost money in the third quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with healthcare among them. Nevertheless, most investors decided to stick to their bullish theses and their long-term focus allows us to profit from the recent declines. In particular, let’s take a look at what hedge funds think about MedAssets, Inc. (NASDAQ:MDAS) in this article.

MedAssets, Inc. (NASDAQ:MDAS) was in 17 hedge funds’ portfolios at the end of September. MDAS shareholders have witnessed an increase in hedge fund sentiment recently. There were 16 hedge funds in our database with MDAS positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Tumi Holdings Inc (NYSE:TUMI), Penumbra Inc (NYSE:PEN), and Sonic Corporation (NASDAQ:SONC) to gather more data points.

Follow Medassets Inc (NASDAQ:MDAS)
Trade (NASDAQ:MDAS) Now!

If you’d ask most shareholders, hedge funds are perceived as slow, old financial tools of yesteryear. While there are over 8,000 funds trading today, We hone in on the elite of this club, around 700 funds. These investment experts shepherd most of all hedge funds’ total asset base, and by shadowing their highest performing picks, Insider Monkey has brought to light a number of investment strategies that have historically surpassed Mr. Market. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

With all of this in mind, we’re going to view the new action regarding MedAssets, Inc. (NASDAQ:MDAS).

How have hedgies been trading MedAssets, Inc. (NASDAQ:MDAS)?

At the end of the third quarter, a total of 17 of the hedge funds tracked by Insider Monkey were long this stock, a change of 6% from the previous quarter. With hedge funds’ sentiment swirling, there exists a select group of noteworthy hedge fund managers who were boosting their stakes considerably (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Starboard Value LP, managed by Jeffrey Smith, holds the largest position in MedAssets, Inc. (NASDAQ:MDAS). Starboard Value LP has a $106.8 million position in the stock, comprising 2.4% of its 13F portfolio. On Starboard Value LP’s heels is Jamie Zimmerman of Litespeed Management, with a $65.7 million position; 8.1% of its 13F portfolio is allocated to the company. Other peers that are bullish contain Claus Moller’s P2 Capital Partners, Michael Lowenstein’s Kensico Capital and Michael Doheny’s Freshford Capital Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.